Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis

Citation
E. Stolz et al., Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis, ACT NEUR SC, 102(1), 2000, pp. 31-36
Citations number
35
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
ACTA NEUROLOGICA SCANDINAVICA
ISSN journal
00016314 → ACNP
Volume
102
Issue
1
Year of publication
2000
Pages
31 - 36
Database
ISI
SICI code
0001-6314(200007)102:1<31:SFTRFA>2.0.ZU;2-G
Abstract
Objectives - In this study the frequency of inherited thrombophilic risk fa ctors in a population of German CVT patients and their influence on clinica l outcome were evaluated. Material and methods - Twenty-five patients (age 37.1 +/- 16.3 years) with CVT were screened for inherited coagulation disor ders. All participants received a full clinical follow-up (mean follow-up p eriod 4.8 +/- 6.4 years). Results - Inherited thrombophilic risk factors we re identified in 9 (36%) of the 25 patients studied. Four were found positi ve for the heterozygous factor V Leiden mutation, 2 were heterozygous carri ers of the prothrombin-G20210A-polymorphism. APC resistance proved to be a reliable screening method for factor V Leiden mutation, whereas genetic eva luation for protein S and C deficiencies failed to demonstrate any mutation s despite the identification of 1 patient with a protein C and protein S de ficiency each. One patient suffered from a familial plasminogen deficiency. These 9 patients had a less favorable outcome (P < 0.05). Conclusion - Our results demonstrate that screening for inherited thrombophilia should be a n integral part in the diagnostic work up of CVT patients. Patients with in herited coagulopathies tended to have a less favorable outcome, corroborati ng recommendations for a longer period of oral anticoagulation.